Why is Windlas Biotech falling/rising?

As of 04-Sep, Windlas Biotech Ltd's stock price is currently at 985.45, reflecting an increase of 2.25 or 0.23%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 1.28%. However, it has underperformed the broader market in the short term, with a 1-week return of -0.97% compared to the Sensex's increase of +0.80%. Despite this, the company has demonstrated strong financial performance, achieving record net sales and profits in its latest quarterly results, along with a low debt-to-equity ratio. The stock is trading at a premium relative to its peers, which may indicate investor confidence, although the falling delivery volume suggests a decrease in investor participation.
In the broader market context, Windlas Biotech's recent performance contrasts with the Sensex, which has shown a positive return over the same period. While the stock has generated a commendable 10.20% return over the past year, its year-to-date performance is down by 4.64%, indicating challenges in maintaining momentum. The company's consistent returns over the last three years and a fair valuation may support its price, but concerns about long-term growth, as indicated by a slower operating profit growth rate, could weigh on investor sentiment moving forward.